"Designing Growth Strategies is in our DNA"

Endocrine Testing Market Size, Share & Industry Analysis, By Technology (Immunoassay, Tandem Mass Spectroscopy, Chromatography, Clinical Chemistry Technology, Others), By End User (Hospitals, Diagnostic Laboratories, Ambulatory Care Centers, Others) And Regional Forecast, 2024-2032

Region :Global | Report ID: FBI104462 | Status : Ongoing

 

KEY MARKET INSIGHTS

Endocrine glands are responsible for making the hormones that our body needs and regulating how they work. Endocrine disorders results due to the improper functioning of endrocrine glands and are unable to produce the right amount of hormones. Endocrine testing thus helps in diagnosing hormonal disorders and plan the best cousre of treatment. The rising  geriatric, diabetic, and obese population is anticipated to favor the market growth. For instance, according to research article published by United Nations, in 2019, there were around 703 million persons aged 65 years or over, globally. Moreover, growing healthcare awareness coupled with rising advancements in testing technologies are contributing towards the growth of the market.


The endocrine testing market is expected to register a significant growth during the forecast period due to factors such rising number of cases of lifestyle diseases, escalating health-consciousness, growing number of product approvals for the diagnostic test of endocrine disorders. However, high cost of the tests is the major factor anticipated to hamper the growth of endocrine testing market.

Up Arrow

Key Market Driver -

Rising prevalence of diabetes, rise in geriatric population

Down Arrow

Key Market Restraint -

High cost of the tests


Market Segmentation:


Globally, the endocrine testing market can be segmented on the basis of the technology, end user, and region. Based on the technology, the market can be segmented into immunoassay, tandem mass spectroscopy, chromatography, clinical chemistry technology, and others. Based on end user, the market can be segmented into hospitals, diagnostic laboratories, ambulatory care centers, and others. Geographically, the endocrine testing market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Key Players Covered:


Some of the major companies that are present in the endocrine testing market are Abbott, DH Tech. Dev. Pte. Ltd., Agilent Technologies, Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Beckman Coulter, Inc. and other prominent players.

Key Insights:



  • Key Industry Trends

  • Technological Advancements in Endocrine Testing

  • New Product Launches

  • Key Industry Developments Mergers, Acquisitions, And Collaborations


Regional Analysis:


Geographically, the endocrine testing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to account for maximum share of the endocrine testing market. The dominance is attributable to the increasing incidence of endocrinal disorders, well developed healthcare sector, and high spending capacity of the population. For instance, according to Center for Disease Control and Prevention, in 2018, 34.2 million (10%) people of all ages had diabetes in U.S. Europe is likely to hold the second largest market share during the forecast period. Increasing geriatric population and highly aware population is likely to spur the market growth in this region. On the other hand, Asia Pacific is expected to register the highest CAGR owing to the rising economic stability, growing awareness among the population and rising prevalence of endocrine disorders. The market in Latin America and the Middle East & Africa are in nascent stage. However, growing geriatric population coupled with increasing susceptibility to various endocrine disorders in these regions are likely to help witness a considerable growth in the market in the upcoming years.

To gain extensive insights into the market, Request for Customization


Segmentation






















  ATTRIBUTE

  DETAILS

By Technology



  • Immunoassay

  • Tandem Mass Spectroscopy

  • Chromatography

  • Clinical Chemistry Technology

  • Others



By End User



  • Hospitals

  • Diagnostic Laboratories

  • Ambulatory Care Centers

  • Others



By Geography



  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Endocrine Testing Market Industry Developments



  • In August 2020, DiaSorin received CE mark for Liaison Testosterone xt test to measure testosterone in women and men, to detect fertility disorders

  • In December 2018, USFDA approved the new blood test to determine amount of anti-Müllerian hormone (AMH) in the blood for menopause





  • Ongoing
  • 2023
  • 2019-2022
  • Pre Book
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
Jubilant
Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X